2m 2m 2m 2m 2m 2m 2m
ADIAL PHRMCTCLS (ADIL)
NASDAQ
$4.96+$0.06 (+1.22%)
Price as of Sep 11, 2026 7:51 PM EDT- $14.4MMarket Cap
- -44.00%1-Year Change
- BiotechnologyIndustry
ADIAL PHRMCTCLS (ADIL)
$4.96+$0.06 (+1.22%)
ADIL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.90 | ||
Change | -$1.09 (-18.27%) | ||
Open | $6.06 | ||
High | $6.11 | ||
Low | $4.80 | ||
Previous Close | $6.00 | ||
Volume | 108,475 | ||
30-Day Average Volume | 68,455 | ||
1-Week Change | -31.18% | ||
1-Month Change | 13.69% | ||
1-Year Change | -44.00% | ||
3-Year Change | -94.02% | ||
5-Year Change | -99.81% | ||
Fundamentals | |||
Shares Outstanding | 2.9M | ||
Total Assets | $29.1M | ||
Market Cap | $14.4M | ||
Enterprise Value | -$14.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$6.4M | ||
EBIT | $0.00 | ||
EBITDA | $0.00 | ||
Net Working Capital | $23.7M | ||
EPS | -$11.25 | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | -0 | ||
P/E | -0 | ||
PEG | 0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 02/06/2026 | ||
Earnings & Revenue